
Recently, the National Pharmaceutical Project successfully won the bid for the Yanjiao Vaccine Production Base Project (Phase I) of Beijing Baihui Biotechnology Co., Ltd.
The project covers an area of about94 mu, total planned investment24 billions of dollars. The total construction area of the first phase of the project is about6.9 ten thousand square meters,
It aims to build a local vaccine R & D, production and sales of the whole chain ecosystem, promote the vaccine industry agglomeration, accelerate technological innovation and achievement transformation, and improve regional and even national public health safety level.(Headquarters Process Design Office contribution)